Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXYBAR: Impact of Hyperbaric Oxygen Therapy on DNA Damage in Radiotherapy Patients
NCT06999785Recruiting
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Jul 2025
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Trial, sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Correlation between hyperbaric oxygen therapy and DNA damages. Started Jul 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06999785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999785.